HYDRO-RESERP Drug Patent Profile
✉ Email this page to a colleague
When do Hydro-reserp patents expire, and what generic alternatives are available?
Hydro-reserp is a drug marketed by Abc Holding and is included in one NDA.
The generic ingredient in HYDRO-RESERP is hydrochlorothiazide; reserpine. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; reserpine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDRO-RESERP?
- What are the global sales for HYDRO-RESERP?
- What is Average Wholesale Price for HYDRO-RESERP?
Summary for HYDRO-RESERP
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 84 |
| DailyMed Link: | HYDRO-RESERP at DailyMed |
US Patents and Regulatory Information for HYDRO-RESERP
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abc Holding | HYDRO-RESERP | hydrochlorothiazide; reserpine | TABLET;ORAL | 084714-002 | Jun 29, 1982 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
